Hot Life Science Investor Mandate 3: Global VC Seeking Therapeutics and Diagnostics with Early Human Data

14 Aug

A Venture Capital company with offices all around the globe is currently looking to make equity investments generally ranging from $5 to $25 million. The firm has no set number of investments it plans to make over the next 6-9 months but is actively reviewing companies for investment. The firm is willing to pursue opportunities located globally.

The firm is looking for companies in sectors of Biotechnology Therapeutics, Diagnostics, and Nutrition/Food. The firm is most interested in areas of brain health, GI (gastro intestinal), metabolic disorders and aging. The firm typically looks for early human clinical data and focused on compounds (both small molecules and biologics) with a strong safety profile that are suitable for chronic use, along with strong IP protection and a scientific rationale for their effect.

The is looking for management teams with domain expertise and a strong track record and generally looks to take a board seat following investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: